Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis

Regulatory T cells (Tregs) are critical for maintaining immune tolerance by suppressing effector T cell responses. However, in chronic inflammatory diseases such as spondyloarthritis (SpA) and psoriasis (PsO), Tregs can lose their stability and acquire pro-inflammatory characteristics, a phenomenon...

Full description

Saved in:
Bibliographic Details
Main Authors: Ingrid Itzayanna Ortega-Mejia, Nayeli Romero-López, Julio César Casasola-Vargas, Rubén Burgos-Vargas, María Lilia Domínguez-López, José Pablo Romero-López
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1621396/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849418744532566016
author Ingrid Itzayanna Ortega-Mejia
Ingrid Itzayanna Ortega-Mejia
Nayeli Romero-López
Nayeli Romero-López
Julio César Casasola-Vargas
Rubén Burgos-Vargas
María Lilia Domínguez-López
José Pablo Romero-López
author_facet Ingrid Itzayanna Ortega-Mejia
Ingrid Itzayanna Ortega-Mejia
Nayeli Romero-López
Nayeli Romero-López
Julio César Casasola-Vargas
Rubén Burgos-Vargas
María Lilia Domínguez-López
José Pablo Romero-López
author_sort Ingrid Itzayanna Ortega-Mejia
collection DOAJ
description Regulatory T cells (Tregs) are critical for maintaining immune tolerance by suppressing effector T cell responses. However, in chronic inflammatory diseases such as spondyloarthritis (SpA) and psoriasis (PsO), Tregs can lose their stability and acquire pro-inflammatory characteristics, a phenomenon known as Treg plasticity. Under inflammatory conditions, Tregs may downregulate FoxP3, upregulate RORγt, and produce cytokines such as IL-17 and IFN-γ, thus losing their suppressive function and contributing to disease progression. In SpA, altered numbers and impaired Treg function have been identified in peripheral blood and synovial fluid. Specific subsets, such as CD161+ Tregs with Th17-like features, suggest that inflammatory cytokines and signals like STAT3 activation and ICOS engagement promote pathogenic reprogramming. Genetic factors, including HLA-B27, may further predispose Tregs to instability. Single-cell transcriptomic analyses have provided evidence of shared TCR repertoires between Tregs and effector T cells, reinforcing the concept of lineage plasticity. Similarly, in PsO, skin-resident Tregs exposed to IL-23, IL-6, and IL-21 can acquire a Th17-like phenotype, producing IL-17A and exacerbating local inflammation. Environmental factors such as hypoxia also contribute to destabilizing Treg identity. The persistence of pathogenic Tregs, even following therapy blockade of IL-17 or IL-23, highlights the challenge of achieving long-term disease remission.
format Article
id doaj-art-12dc4e56fab4408fa75bbd7e52802756
institution Kabale University
issn 1664-3224
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-12dc4e56fab4408fa75bbd7e528027562025-08-20T03:32:20ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.16213961621396Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasisIngrid Itzayanna Ortega-Mejia0Ingrid Itzayanna Ortega-Mejia1Nayeli Romero-López2Nayeli Romero-López3Julio César Casasola-Vargas4Rubén Burgos-Vargas5María Lilia Domínguez-López6José Pablo Romero-López7Laboratorio de Patogénesis Molecular, Edificio A4, Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM), Tlalnepantla de Baz, Estado de Mexico, MexicoLaboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de Mexico, MexicoLaboratorio de Patogénesis Molecular, Edificio A4, Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM), Tlalnepantla de Baz, Estado de Mexico, MexicoLaboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de Mexico, MexicoDepartment of Rheumatology Hospital General Dr. Eduardo Liceaga, Ciudad de Mexico, MexicoDepartment of Rheumatology Hospital General Dr. Eduardo Liceaga, Ciudad de Mexico, MexicoLaboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de Mexico, MexicoLaboratorio de Patogénesis Molecular, Edificio A4, Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM), Tlalnepantla de Baz, Estado de Mexico, MexicoRegulatory T cells (Tregs) are critical for maintaining immune tolerance by suppressing effector T cell responses. However, in chronic inflammatory diseases such as spondyloarthritis (SpA) and psoriasis (PsO), Tregs can lose their stability and acquire pro-inflammatory characteristics, a phenomenon known as Treg plasticity. Under inflammatory conditions, Tregs may downregulate FoxP3, upregulate RORγt, and produce cytokines such as IL-17 and IFN-γ, thus losing their suppressive function and contributing to disease progression. In SpA, altered numbers and impaired Treg function have been identified in peripheral blood and synovial fluid. Specific subsets, such as CD161+ Tregs with Th17-like features, suggest that inflammatory cytokines and signals like STAT3 activation and ICOS engagement promote pathogenic reprogramming. Genetic factors, including HLA-B27, may further predispose Tregs to instability. Single-cell transcriptomic analyses have provided evidence of shared TCR repertoires between Tregs and effector T cells, reinforcing the concept of lineage plasticity. Similarly, in PsO, skin-resident Tregs exposed to IL-23, IL-6, and IL-21 can acquire a Th17-like phenotype, producing IL-17A and exacerbating local inflammation. Environmental factors such as hypoxia also contribute to destabilizing Treg identity. The persistence of pathogenic Tregs, even following therapy blockade of IL-17 or IL-23, highlights the challenge of achieving long-term disease remission.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1621396/fullTreg cellsTreg plasticityIL-17spondyloarthritispsoriasis
spellingShingle Ingrid Itzayanna Ortega-Mejia
Ingrid Itzayanna Ortega-Mejia
Nayeli Romero-López
Nayeli Romero-López
Julio César Casasola-Vargas
Rubén Burgos-Vargas
María Lilia Domínguez-López
José Pablo Romero-López
Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis
Frontiers in Immunology
Treg cells
Treg plasticity
IL-17
spondyloarthritis
psoriasis
title Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis
title_full Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis
title_fullStr Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis
title_full_unstemmed Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis
title_short Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis
title_sort treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis
topic Treg cells
Treg plasticity
IL-17
spondyloarthritis
psoriasis
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1621396/full
work_keys_str_mv AT ingriditzayannaortegamejia tregcellplasticityasadriverofinflammationinspondyloarthritisandpsoriasis
AT ingriditzayannaortegamejia tregcellplasticityasadriverofinflammationinspondyloarthritisandpsoriasis
AT nayeliromerolopez tregcellplasticityasadriverofinflammationinspondyloarthritisandpsoriasis
AT nayeliromerolopez tregcellplasticityasadriverofinflammationinspondyloarthritisandpsoriasis
AT juliocesarcasasolavargas tregcellplasticityasadriverofinflammationinspondyloarthritisandpsoriasis
AT rubenburgosvargas tregcellplasticityasadriverofinflammationinspondyloarthritisandpsoriasis
AT marialiliadominguezlopez tregcellplasticityasadriverofinflammationinspondyloarthritisandpsoriasis
AT josepabloromerolopez tregcellplasticityasadriverofinflammationinspondyloarthritisandpsoriasis